课题基金 / 基金详情

OPEN LABEL STUDY OF SNXIII TO PATIENTS SUFFERING CHRONIC PAIN

OPEN LABEL STUDY OF SNXIII TO PATIENTS SUFFERING CHRONIC PAIN
SNXIII 对慢性疼痛患者的开放标签研究
批准号：
6279201
负责人：
MARK S WALLACE
金额：
$1.43万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6279201
关键词：
chronic pain clinical research drug administration routes drug adverse effect drug screening /evaluation human subject

项目摘要

项目成果

MARK S WALLACE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Assess the long-term safety, efficacy and tolerability of snx-111 administered intrathetcally to patients who suffer from chronic, intractable pain and have participated in a peviousy snx-111 study. Safety and performance of synchromed infusion system will be assessed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
California Clinical and Translational Pain Research Consortium
EFFICACY OF INHALED CANNABIS FOR THE TREATMENT OF PAINFUL DIABETIC NEUROPATHY
EFFICACY OF INHALED CANNABIS FOR THE TREATMENT OF PAINFUL DIABETIC NEUROPATHY
EFFECTS OF SPINAL CORD STIMULATION ON EXPERIMENTALLY INDUCED WIND-UP
海外基金